Targeted Biologics and Selective Sodium Blockers Drive Modern Shifts in Chronic Pain Therapies
A comprehensive pharmacological review evaluates how emerging antibodies, subtype-selective ion channel inhibitors, and genetic screening criteria are reshaping the clinical ...


